Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

←Back to companies

CDI · NZX

CDL Investments New Zealand (CDI)

Property / Residential development•Covered: FY21 - FY25•9 published briefings

CDL Investments New Zealand is an NZX-listed property / residential development company with FY21 - FY25 of published result briefings.

Latest briefing

FY25 · Released 24 February 2026

PBT fell 42.5% as margin reset to an unprecedented 40.4%

Tax-rate normalisation cushioned NPAT to a 27.9% decline, masking a deeper margin compression on subdued residential section demand.

Market data

As at close
Close price
NZD 0.72
Market cap
$211m
Dividend yield
1.4%

as at close, 16 June 2026. Source: yfinance.

Sections⌄
  1. Snapshot
  2. Valuation
  3. Chat
  4. Longitudinal View
  5. Follow-through
  6. Archive
  7. Related Insights
  1. Snapshot
  2. Valuation
  3. Chat
  4. Longitudinal View
  5. Follow-through
  6. Archive
  7. Related Insights

Snapshot

Latest metrics

FY25, released 24 February 2026

← Swipe to view more
CDI latest metrics
MetricValueChange
Revenue$38.1m↓ -22.3%
EBITDA$15.6m↓ -37.4%
NPAT$11.1m↓ -27.9%
Operating cash flow-$9m↓ -10.6%
OCF / EBITDA %-57.5%↓ -25.0pp
ROE %3.5%Outside range lowOutside range low roe. 3.5%; 4-period range 4.3% to 10.9%. ROE: 3.5%, below normal range; 4-period mean 7.6%, range 4.3%-10.9%.↓ -1.3pp
DPS1.0c↓ -71.4%
Payout ratio vs NPAT %26.5%Outside range lowOutside range low payout ratio versus npat. 26.5%; 4-period range 31.9% to 75.4%. Payout ratio versus NPAT: 26.5%, below normal range; 4-period mean 51.5%, range 31.9%-75.4%.↓ -39.8pp
Annual payout ratio vs EPS %26.5%↓ -39.8pp
PBT$15.4m↓ -42.5%

Source: latest published briefing (FY25, released 24 February 2026). Change compares against the prior equivalent period: FY24, released 24 February 2025.

Valuation

Valuation

A compact read on what the market price implies next to the latest filing data. The numbers are a starting point for comparison, not a recommendation.

Prices as at close, 16 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$211m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

19.01x

i

Recent market cap compared with trailing earnings.

EPS

0.04

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not meaningful without positive comparable earnings growth.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

Not available

i

Not meaningful when free cash flow is negative or unavailable.

P/B

0.66x

i

Market value compared with latest reported equity.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

1.4%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Price history

Daily closes use the full available width, with hover and touch readouts against real observations. Expand opens the chart at reading size.

Share price

Five years of daily closes, as at close, 5 June 2026. Weekends, suspensions, and listing gaps stay as natural gaps in the time scale.

↗
Loading chart...

Price vs earnings

Indexed lines compare direction from the first positive comparable filing point. The axis is an index, not dollars or cents.

↗
Loading chart...

Chat

Ask about CDI

Ask follow-up questions about CDL Investments New Zealand's latest result and company history.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about CDI

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask company questions.

What changed in the latest result?What is unusual in the historical context?How has cash conversion changed over time?Compare this company with CNU.

Checking account...

Longitudinal view

Performance over time

The latest period is shown first.

← Swipe to view more
CDI metric history
MetricFY2512 MONTHS24 February 2026HY256 MONTHS12 August 2025FY2412 MONTHS24 February 2025HY246 MONTHS7 August 2024FY2312 MONTHS26 February 2024HY236 MONTHS8 August 2023FY2212 MONTHS16 February 2023HY226 MONTHS10 August 2022FY2112 MONTHS18 February 2022Trend
Revenue$38.1m$13.8m$49.1m$16.6m$30.8m$11.8m$67.1m$47.6m$91.9m
Chart
Revenue growth %-22.3%-17.2%59.4%Unprecedented highUnprecedented high revenue growth. 59.4%; 4-period range -54.1% to 3.7%. Revenue growth: 59.4%, unprecedented high; 4-period mean -24.9%, range -54.1%-3.7%.40.3%Outside range highOutside range high revenue growth. 40.3%; 3-period range -75.1% to -17.2%. Revenue growth: 40.3%, above normal range; 3-period mean -38.2%, range -75.1%--17.2%.-54.1%Outside range lowOutside range low revenue growth. -54.1%; 4-period range -27% to 59.4%. Revenue growth: -54.1%, below normal range; 4-period mean 3.4%, range -27.0%-59.4%.-75.1%Outside range lowOutside range low revenue growth. -75.1%; 3-period range -22.2% to 40.3%. Revenue growth: -75.1%, below normal range; 3-period mean 0.3%, range -22.2%-40.3%.-27.0%-22.2%3.7%
Chart
  • FY23 Revenue growth %: Outside range low revenue growth. -54.1%; 4-period range -27% to 59.4%. Revenue growth: -54.1%, below normal range; 4-period mean 3.4%, range -27.0%-59.4%.
  • HY24 Revenue growth %: Outside range high revenue growth. 40.3%; 3-period range -75.1% to -17.2%. Revenue growth: 40.3%, above normal range; 3-period mean -38.2%, range -75.1%--17.2%.
  • FY24 Revenue growth %: Unprecedented high revenue growth. 59.4%; 4-period range -54.1% to 3.7%. Revenue growth: 59.4%, unprecedented high; 4-period mean -24.9%, range -54.1%-3.7%.
EBITDA$15.6m$5.1m$25m$7.9m$16.2m$5.3m———
Chart
EBITDA margin %41.0%37.1%50.9%47.6%52.5%44.7%———
Chart
PBT$15.4m$5.1m$26.8m$9.2m$18.7m$7m$43.3m$31.8m$43.4m
Chart
PBT growth %-42.5%-44.6%43.3%Unprecedented highUnprecedented high pbt growth. 43.3%; 4-period range -56.8% to 3.8%. PBT growth: 43.3%, unprecedented high; 4-period mean -23.9%, range -56.8%-3.8%.31.4%Outside range highOutside range high pbt growth. 31.4%; 3-period range -78% to 10.4%. PBT growth: 31.4%, above normal range; 3-period mean -37.4%, range -78.0%-10.4%.-56.8%Outside range lowOutside range low pbt growth. -56.8%; 4-period range -42.5% to 43.3%. PBT growth: -56.8%, below normal range; 4-period mean 1.1%, range -42.5%-43.3%.-78.0%Outside range lowOutside range low pbt growth. -78%; 3-period range -44.6% to 31.4%. PBT growth: -78.0%, below normal range; 3-period mean -0.9%, range -44.6%-31.4%.-0.2%10.4%3.8%
Chart
  • FY23 PBT growth %: Outside range low pbt growth. -56.8%; 4-period range -42.5% to 43.3%. PBT growth: -56.8%, below normal range; 4-period mean 1.1%, range -42.5%-43.3%.
  • HY24 PBT growth %: Outside range high pbt growth. 31.4%; 3-period range -78% to 10.4%. PBT growth: 31.4%, above normal range; 3-period mean -37.4%, range -78.0%-10.4%.
  • FY24 PBT growth %: Unprecedented high pbt growth. 43.3%; 4-period range -56.8% to 3.8%. PBT growth: 43.3%, unprecedented high; 4-period mean -23.9%, range -56.8%-3.8%.
NPAT$11.1m$3.6m$15.4m$2.7m$13.5m$5m$31.2m$22.9m$31.3m
Chart
NPAT growth %-27.9%33.3%Outside range highOutside range high npat growth. 33.3%; 3-period range -78.2% to 10.1%. NPAT growth: 33.3%, above normal range; 3-period mean -38.0%, range -78.2%-10.1%.14.1%Outside range highOutside range high npat growth. 14.1%; 4-period range -56.7% to 4%. NPAT growth: 14.1%, above normal range; 4-period mean -20.2%, range -56.7%-4.0%.-46.0%-56.7%Unprecedented lowUnprecedented low npat growth. -56.7%; 4-period range -27.9% to 14.1%. NPAT growth: -56.7%, unprecedented low; 4-period mean -2.5%, range -27.9%-14.1%.-78.2%Outside range lowOutside range low npat growth. -78.2%; 3-period range -46% to 33.3%. NPAT growth: -78.2%, below normal range; 3-period mean -0.9%, range -46.0%-33.3%.-0.3%10.1%4.0%
Chart
  • FY23 NPAT growth %: Unprecedented low npat growth. -56.7%; 4-period range -27.9% to 14.1%. NPAT growth: -56.7%, unprecedented low; 4-period mean -2.5%, range -27.9%-14.1%.
  • FY24 NPAT growth %: Outside range high npat growth. 14.1%; 4-period range -56.7% to 4%. NPAT growth: 14.1%, above normal range; 4-period mean -20.2%, range -56.7%-4.0%.
  • HY25 NPAT growth %: Outside range high npat growth. 33.3%; 3-period range -78.2% to 10.1%. NPAT growth: 33.3%, above normal range; 3-period mean -38.0%, range -78.2%-10.1%.
Operating cash flow-$9m-$12.2m-$8.1m-$6.5m-$10.3m$2.5m$11.2m$10.8m$4.1m
Chart
OCF / EBITDA %-57.5%-239.4%-32.5%-82.5%-63.7%47.1%———
Chart
FCF pre-lease-$9m-$12.6m-$9.1m-$6.6m-$10.3m$2.2m$11.2m—$4.1m
Chart
FCF post-lease——-$9.1m-$6.6m——$11.2m—$4.1m
Chart
DPS1.0c—3.5c—3.5c—3.5c—3.5c
Chart
Payout ratio vs NPAT %26.5%Outside range lowOutside range low payout ratio versus npat. 26.5%; 4-period range 31.9% to 75.4%. Payout ratio versus NPAT: 26.5%, below normal range; 4-period mean 51.5%, range 31.9%-75.4%.—66.3%—75.4%Unprecedented highUnprecedented high payout ratio versus npat. 75.4%; 4-period range 26.5% to 66.3%. Payout ratio versus NPAT: 75.4%, unprecedented high; 4-period mean 39.3%, range 26.5%-66.3%.—32.4%—31.9%
Chart
  • FY23 Payout ratio vs NPAT %: Unprecedented high payout ratio versus npat. 75.4%; 4-period range 26.5% to 66.3%. Payout ratio versus NPAT: 75.4%, unprecedented high; 4-period mean 39.3%, range 26.5%-66.3%.
  • FY25 Payout ratio vs NPAT %: Outside range low payout ratio versus npat. 26.5%; 4-period range 31.9% to 75.4%. Payout ratio versus NPAT: 26.5%, below normal range; 4-period mean 51.5%, range 31.9%-75.4%.
Annual payout ratio vs EPS %26.5%—66.3%—75.4%—32.3%—31.9%
Chart
ROE %3.5%Outside range lowOutside range low roe. 3.5%; 4-period range 4.3% to 10.9%. ROE: 3.5%, below normal range; 4-period mean 7.6%, range 4.3%-10.9%.1.1%Outside range lowOutside range low roe. 1.1%; 3-period range 1.6% to 7.6%. ROE: 1.1%, below normal range; 3-period mean 3.7%, range 1.6%-7.6%.4.8%1.8%4.3%1.6%10.5%7.6%Outside range highOutside range high roe. 7.6%; 3-period range 1.1% to 1.8%. ROE: 7.6%, above normal range; 3-period mean 1.5%, range 1.1%-1.8%.10.9%Outside range highOutside range high roe. 10.9%; 4-period range 3.5% to 10.5%. ROE: 10.9%, above normal range; 4-period mean 5.8%, range 3.5%-10.5%.
Chart
  • HY25 ROE %: Outside range low roe. 1.1%; 3-period range 1.6% to 7.6%. ROE: 1.1%, below normal range; 3-period mean 3.7%, range 1.6%-7.6%.
  • FY25 ROE %: Outside range low roe. 3.5%; 4-period range 4.3% to 10.9%. ROE: 3.5%, below normal range; 4-period mean 7.6%, range 4.3%-10.9%.
Debtor days4505Outside range highOutside range high debtor days. 5d; 4-period range 0d to 4d. Debtor days: 5.0 days, above normal range; 4-period mean 2.3 days, range 0.4 days-3.9 days.76Outside range highOutside range high debtor days. 76d; 3-period range 6d to 56d. Debtor days: 76.1 days, above normal range; 3-period mean 37.2 days, range 5.7 days-55.9 days.45616Outside range lowOutside range low debtor days. 6d; 3-period range 50d to 76d. Debtor days: 5.7 days, below normal range; 3-period mean 60.7 days, range 50.0 days-76.1 days.0Unprecedented lowUnprecedented low debtor days. 0d; 4-period range 1d to 5d. Debtor days: 0.4 days, unprecedented low; 4-period mean 3.5 days, range 1.2 days-5.0 days.
Chart
  • HY24 Debtor days: Outside range high debtor days. 76d; 3-period range 6d to 56d. Debtor days: 76.1 days, above normal range; 3-period mean 37.2 days, range 5.7 days-55.9 days.
  • FY24 Debtor days: Outside range high debtor days. 5d; 4-period range 0d to 4d. Debtor days: 5.0 days, above normal range; 4-period mean 2.3 days, range 0.4 days-3.9 days.
Total assets$331.6m$323.9m$328.6m$313.5m$319.2m$306.5m$313.7m$306.7m$297.6m
Chart

Reference: annolyse.ai/companies/cdi

Note: Figures are shown as reported. Half-year and full-year absolute values are not directly comparable. Growth rates and ratios are the meaningful comparison across mixed periods.

Filing-only history charts

These charts use verified published filing periods only. Gaps are not interpolated, and mixed half-year/full-year histories are split into separate series.

Revenue

Reported revenue across covered periods.

↗
Loading chart...

Revenue growth

Like-period revenue growth where comparable.

↗
Loading chart...
  • FY23 CDI FY: Outside range low revenue growth. -54.1%; 4-period range -27% to 59.4%. Revenue growth: -54.1%, below normal range; 4-period mean 3.4%, range -27.0%-59.4%.
  • FY24 CDI FY: Unprecedented high revenue growth. 59.4%; 4-period range -54.1% to 3.7%. Revenue growth: 59.4%, unprecedented high; 4-period mean -24.9%, range -54.1%-3.7%.
  • HY23 CDI HY: Outside range low revenue growth. -75.1%; 3-period range -22.2% to 40.3%. Revenue growth: -75.1%, below normal range; 3-period mean 0.3%, range -22.2%-40.3%.
  • HY24 CDI HY: Outside range high revenue growth. 40.3%; 3-period range -75.1% to -17.2%. Revenue growth: 40.3%, above normal range; 3-period mean -38.2%, range -75.1%--17.2%.

EBITDA-equivalent

Company-specific earnings measure where disclosed.

↗
Loading chart...

EBITDA margin

EBITDA-equivalent margin where revenue and earnings are source-backed.

↗
Loading chart...

NPAT

Statutory profit after tax.

↗
Loading chart...

Operating cash flow

Cash generated from operations.

↗
Loading chart...

Full chartable metric set

Additional verified filing metrics for this company. Each point links back to a published briefing period in the source data contract.

OCF / EBITDA

Cash conversion against earnings.

↗
Loading chart...

FCF pre-lease

Operating cash flow less capex before leases.

↗
Loading chart...

FCF post-lease

Free cash flow after lease payments where available.

↗
Loading chart...

ROE

Return on equity.

↗
Loading chart...
  • FY21 CDI FY: Outside range high roe. 10.9%; 4-period range 3.5% to 10.5%. ROE: 10.9%, above normal range; 4-period mean 5.8%, range 3.5%-10.5%.
  • FY25 CDI FY: Outside range low roe. 3.5%; 4-period range 4.3% to 10.9%. ROE: 3.5%, below normal range; 4-period mean 7.6%, range 4.3%-10.9%.
  • HY22 CDI HY: Outside range high roe. 7.6%; 3-period range 1.1% to 1.8%. ROE: 7.6%, above normal range; 3-period mean 1.5%, range 1.1%-1.8%.
  • HY25 CDI HY: Outside range low roe. 1.1%; 3-period range 1.6% to 7.6%. ROE: 1.1%, below normal range; 3-period mean 3.7%, range 1.6%-7.6%.

DPS

Dividend per share declared for the period.

↗
Loading chart...

Payout ratio

Dividend payout against statutory NPAT.

↗
Loading chart...
  • FY23 CDI FY: Unprecedented high payout ratio versus npat. 75.4%; 4-period range 26.5% to 66.3%. Payout ratio versus NPAT: 75.4%, unprecedented high; 4-period mean 39.3%, range 26.5%-66.3%.
  • FY25 CDI FY: Outside range low payout ratio versus npat. 26.5%; 4-period range 31.9% to 75.4%. Payout ratio versus NPAT: 26.5%, below normal range; 4-period mean 51.5%, range 31.9%-75.4%.

Debtor days

Receivables days where the working-capital inputs are source-backed.

↗
Loading chart...
  • FY21 CDI FY: Unprecedented low debtor days. 0d; 4-period range 1d to 5d. Debtor days: 0.4 days, unprecedented low; 4-period mean 3.5 days, range 1.2 days-5.0 days.
  • FY24 CDI FY: Outside range high debtor days. 5d; 4-period range 0d to 4d. Debtor days: 5.0 days, above normal range; 4-period mean 2.3 days, range 0.4 days-3.9 days.
  • HY22 CDI HY: Outside range low debtor days. 6d; 3-period range 50d to 76d. Debtor days: 5.7 days, below normal range; 3-period mean 60.7 days, range 50.0 days-76.1 days.
  • HY24 CDI HY: Outside range high debtor days. 76d; 3-period range 6d to 56d. Debtor days: 76.1 days, above normal range; 3-period mean 37.2 days, range 5.7 days-55.9 days.

Operating working-capital movement

Per-period working-capital absorption or release, from the same published history. Positive values are working-capital build; negative values are release.

↗
Loading chart...
  • HY24 CDI: Outside range high operating working-capital movement. $3.3m; 3-period range $-3.1m to $2.1m. Operating working-capital movement: NZ$3.3m, above normal range; 1/3 prior periods had builds averaging NZ$2.1m, and 2 had releases averaging NZ$-2.5m.
  • FY24 CDI: Unprecedented high operating working-capital movement. $0.4m; 4-period range $-0.3m to $0.1m. Operating working-capital movement: NZ$0.4m, unprecedented high; 2/4 prior periods had builds averaging NZ$0.1m, and 1 had releases averaging NZ$-0.3m.
  • HY25 CDI: Outside range low operating working-capital movement. $-3.1m; 3-period range $-1.9m to $3.3m. Operating working-capital movement: NZ$-3.1m, below normal range; 2/3 prior periods had builds averaging NZ$2.7m, and 1 had releases averaging NZ$-1.9m.
  • FY25 CDI: Unprecedented low operating working-capital movement. $-0.3m; 4-period range $0m to $0.4m. Operating working-capital movement: NZ$-0.3m, unprecedented low; 3/4 prior periods had builds averaging NZ$0.2m, and none had a working-capital release.

The setup & the reality

HY25 → FY25 Follow-through

The latest result is checked against what the prior briefing said to watch.

Current result now available

FY25 · Released 24 February 2026

PBT fell 42.5% as margin reset to an unprecedented 40.4%

Tax-rate normalisation cushioned NPAT to a 27.9% decline, masking a deeper margin compression on subdued residential section demand.

Read latest briefing→

Historical setup

What HY25 said to watch

From PBT fell 44.6% as tax normalisation flattered NPAT to +33.3%

No quantitative target or guidance is provided. The supplied seasonality shape for FY24 had HY revenue at 33.9% of full year and HY NPAT at only 17.8%, implying a heavily second-half-weighted business in residential settlements. Annualising HY25 revenue gives NZ$27.5m, well below the FY24 NZ$49.1m base, so a flat full-year outcome would require a stronger second half than HY24 produced.

Management flags first sales from Iona Stage 1 in Havelock North with Stage 2 expected to commence early next year, and notes disappointment with the Future Development Strategy (FDS) process. Both point to project-timing risk around H2 settlement volumes that the release does not quantify.

Open questions

Open questions from HY25

  • Why did the NZ$3.1m reduction in trade debtors not translate into improved operating cash flow, and what specifically absorbed it?
  • What is the expected H2 settlement profile across Prestons, Iona Stage 1 and the wider land bank, given that HY25 ran NZ$2.9m below HY24 revenue?
  • How will the FDS outcome and the Environmental Protection Authority panel process affect the medium-term development pipeline and capital commitment?
  • Is the 29.4% effective tax rate now the run-rate, or are further deferred-tax movements anticipated?
  • What level of further development cash outflow is expected in H2, and does the NZ$10.4m cash balance plus NZ$10.2m of liabilities give adequate headroom without new facilities?

This briefing cannot assess section sell-through pace, settlement timing, or land valuations because the release does not disclose forward-work, contracted-but-unsettled volumes, or independent valuation inputs.

Archive

Briefing archive

Every published Annolyse briefing for this company appears here in reverse chronological order.

FY25 · Released 24 February 2026

PBT fell 42.5% as margin reset to an unprecedented 40.4%

Tax-rate normalisation cushioned NPAT to a 27.9% decline, masking a deeper margin compression on subdued residential section demand.

Read briefing→

HY25 · Released 12 August 2025

PBT fell 44.6% as tax normalisation flattered NPAT to +33.3%

Revenue dropped 17.2% in a subdued property market, and the headline NPAT gain reflects a 29.4% tax rate versus 70.2% prior, not improving operations.

Read briefing→

FY24 · Released 24 February 2025

Tax adjustment masked turnaround: PBT up 43.3% but NPAT only 14.1%

A $3.9m one-off non-cash deferred tax charge lifted the effective tax rate to 42.5%, suppressing reported NPAT despite revenue rising 59.4%.

Read briefing→

HY24 · Released 7 August 2024

Cash dropped 76% to NZ$10.7m as PBT rose 31.4%

Strong property sales lifted PBT 31.4%, but operating cash flow swung to a NZ$6.5m outflow as receivables built and a one-off tax charge cut NPAT

Read briefing→

FY23 · Released 26 February 2024

Maintained dividend pushed payout to unprecedented 75.4% as cash fell 93%

FY23 NPAT fell 56.7% on the absence of one-off land sale gains, but the held 3.5cps dividend now exceeds free cash flow.

Read briefing→

HY23 · Released 8 August 2023

Revenue down 75.1% and NPAT down 78.2% on non-recurring 2022 land sales

The decline is volume-driven against a HY22 boosted by one-off land sales, while cash grew to NZ$45.0m with no debt and margins held within range.

Read briefing→

FY22 · Released 16 February 2023

Revenue fell 27% but NPAT margin hit an unprecedented 46.5%

Project mix held profit virtually flat despite lower settlement volumes, while cash fell NZ$21.4m on the Hamilton land acquisition and dividends.

Read briefing→

HY22 · Released 10 August 2022

NPAT up 10.1% on a 22.2% revenue fall as cash dropped 83.4%

Lot-mix margin expansion lifted profit while a $75.9m cash drain into a Hamilton land acquisition and inventory build reset balance-sheet liquidity.

Read briefing→

FY21 · Released 18 February 2022

Operating cash inflow fell 93% to NZ$4.1m as NPAT advanced 4.0%

Residential development cash generation collapsed from NZ$54.8m prior, leaving FY21 reported earnings well ahead of cash conversion.

Read briefing→

Related insights

Compare this company

The latest CDI metrics also appear in these cross-company views.

Insight

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 14.6pp, with a distortion flag in the result.

Open insight→

Insight

Revenue growth context

Revenue growth was -22.3% for this reporting period.

Open insight→

Insight

Dividend coverage and payout pressure

Dividend payout versus NPAT is 26.5%.

Open insight→

Insight

ROE and capital efficiency

ROE was 3.5%, -1.4pp versus the prior comparable period.

Open insight→

Get notified when CDI publishes

Get the next CDL Investments New Zealand result briefing and five-year history updates by email.